KRA Research Grant Guidelines

1. Categories of Grants

1.1 Student Grants

Student grants are available to DM, DNB, and Fellowship trainees. The number of grants and the grant amount will be determined annually based on the funds available.

Eligibility and submission requirements

● The mentor/guide must be a Life Member of the Indian Rheumatology Association (IRA).

● Across the student-grant categories, a maximum of two proposals may be submitted in a year by a single principal investigator (PI), mentor, or guide.

1.2 Grants for Non-Trainee KRA Members

Eligibility and funding requirements

● The proposed project should have a minimum duration of one year.

● The research should address issues relevant to India.

● Funding may be provided for consumables and manpower.

● A PI, mentor, or guide may have a maximum of two ongoing KRA-funded projects at any given time.

● In a single funding cycle, only one project may be funded for a given PI, mentor, or guide.

● Further grants can be applied only on completion of existing project.

 2. Funding Cycles

The number of grants to be awarded and the quantum of funding available in each cycle will be proposed by the Secretary and Treasurer of the Indian Rheumatology Association – Karnataka Chapter (KRA) and placed before the Research Committee for consideration.

Funding will be considered in two six-monthly cycles. Announcement will be made by email and watsapp to all members by the Secretary.

January–June Cycle

● Proposals received between 15th December to 15th January will be considered.

● Proposals will be reviewed, and the decision will be communicated to the applicant by 15th Februrary.

July–December Cycle

● Proposals received between 15th June to 15th  July will be considered.

● Proposals will be reviewed, and the decision will be communicated to the applicant by 15th August.

 3. Research Proposal Submission

● Research proposals must be submitted in the prescribed format, in PDF format, by the PI, mentor, or guide. The PI/mentor/guide must be a KRA member.

● A call for proposals will be circulated by KRA secretary by email to all members during the first week of December and June for each funding cycle.

● Proposals that do not conform to the prescribed format may be rejected without further consideration.

● The PI, or the guide in the case of a student project, must submit the mandatory declaration provided below.

● Applications must be forwarded by the applicant’s Head of Department in the prescribed format.

● KRA-funded research must acknowledge KRA support in all publications arising from the project.

● An abstract related to the project should be submitted to the annual IRA conference (IRACON)/ KRACON

● Investigators are encouraged to consider the Indian Journal of Rheumatology for submission of the full manuscript.

 4. Evaluation of Proposals

4.1 Research Committee

Each proposal will be reviewed by the KRA Research Committee, comprising:

● Secretary, KRA

● Treasurer, KRA

● Five additional KRA members, who may or may not be members of the Executive Committee (EC)

4.2 Appraisal Process

1. Ethical screening: The proposal will first be assessed for ethical acceptability in relation to human or animal research, as applicable.

2. Studies that fail the ethical screening criterion will be rejected.

3. Proposals that pass the ethical screening will be scored according to the KRA research grant scoring system.

4. The decision of the Research Grants Committee will be final and binding.

 5. Funding

Grant funding will be released in three instalments:

● First instalment – 60%: Released upon submission of confirmation of approval from the relevant Ethics Committee.

● Second instalment – 30%: Released upon submission and acceptance of a satisfactory progress report by 6months, which must be submitted no later than one year after receipt of funding.

● Final instalment – 10%: Released after completion of the work and submission of completion report submitted to the research committee.

Additional Requirements

● Investigators are encouraged to submit KRA-funded studies to the Indian Journal of Rheumatology, the official journal of the IRA.

● Abstracts arising from KRA-funded research must be submitted to the IRA annual conference (IRACON) / KRACON

● After completion of research the work must be presented in KRA academic meeting

● KRA must be formally acknowledged for financial support in all publications arising from KRA-funded research.

● Before recommending a proposal for funding, the Research Committee will verify approval from the relevant Research Ethics Committee. The project title submitted for ethics approval should be identical to the title in the funding proposal.

5. KRA Research Grant Scoring System

Maximum Score: 80 points

1. KRA Involvement / Study Category

The following categories are mutually exclusive:

● KRA-endorsed interventional study: 20 points

● KRA-endorsed observational study: 15 points

● Study with at least five KRA investigators: 10 points

Only one category should be applied to a proposal.

2. Scientific Merit / Research Question / Objectives — 0–10 points

● 10: Clear, focused, important research question with a strong scientific basis

● 7: Reasonably clear research question but with limited depth or novelty

● 3: Vague, poorly defined, or of limited scientific relevance

3. Innovation / Novelty — 0–10 points

● 10: Highly novel concept, approach, or application

● 7: Moderate novelty with incremental advancement

● 3: Little or no innovation

4. Study Design and Methodology — 0–10 points

● 10: Robust and appropriate design, with suitable controls and clearly defined endpoints

● 7: Acceptable design with some limitations

● 3: Inappropriate, inadequately described, or unclear design

5. Feasibility — 0–10 points

● 10: Clearly feasible, with realistic timelines, population, infrastructure, and resources

● 7: Some feasibility concerns

● 3: Not feasible within the proposed setting or resources

6. Clarity and Organization — 0–10 points

● 10: Well structured, concise, and easy to understand

● 7: Some ambiguity or organizational issues

● 3: Poorly written or difficult to understand

7. Expected Outcomes and Translational Value — 0–10 points

● 10: Clearly defined outcomes with strong potential clinical, scientific, or policy implications

● 7: Outcomes reasonably defined but with limited translational relevance

● 3: Outcomes unclear or of limited relevance

Scoring note: The study-category options under Criterion 1 are mutually exclusive and cannot be combined. Criteria 2–7 apply to all studies submitted for KRA funding.

6. Format of Research Proposal

1. Title of the Proposed Research Project

The title should be concise, descriptive, and informative. Where appropriate, the study design may be included in the title.

2. Summary — up to 250 words

Provide a structured summary under the following headings:

● Background

● Novelty

● Objectives

● Methods

● Expected outcome

3. Keywords

Provide six keywords, separated by commas, that best describe the proposed project.

4. Abbreviations

Only standard abbreviations should be used. A maximum of 10 abbreviations may be listed.

5. Background — up to 500 words

Establish the research problem and explain how the research question addresses critical gaps or barriers in scientific knowledge, technical capability, and/or clinical, laboratory, or programmatic practice. Highlight relevance at local, national, and international levels.

6. Literature Review — up to 1,000 words

Provide a cohesive review establishing the rationale for the proposed research question, with reference to key publications. Up to 30 references may be provided in Vancouver style. References will not be included in the word count.

7. Novelty/Innovation — up to 250 words

Describe how the proposal advances current research, knowledge, or clinical practice through novel concepts, approaches, methodologies, instrumentation, or interventions.

8. Study Objectives

Define objectives clearly and measurably. Specify primary and secondary objectives where appropriate. Avoid unnecessary objectives.

9. Methodology — up to 2,000 words

Include:

i. Study Design
Describe the study design, study population, participant selection, inclusion and exclusion criteria, definitions of cases/controls, discontinuation criteria, loss to follow-up, and details of interventions where applicable.

ii. Sample Size
Provide the sample-size and/or power calculation, relevant references, operational definitions, and a participant flow chart where applicable.

iii. Project Implementation Plan
Describe participant enrolment, collaboration, follow-up, sample collection/storage/testing, standardization of new tests, and quality-assurance procedures.

iv. Ethics Review
Describe all applicable ethics and regulatory requirements, informed-consent procedures, documentation, and anticipated risks and benefits.

v. Data Collection and Statistical Analysis Plan
Describe variables, measurement methods, data collection tools, data-entry procedures, analytical platforms, and the statistical methods planned for each study objective.

10. Expected Outcomes — up to 100 words

11. Limitations of the Study — up to 100 words

12. Future Plans Based on Expected Outcomes — up to 100 words

13. Timelines

Provide timelines for preparation, data collection, analysis, and report/manuscript preparation.

14. Institutional Support

Describe inter-departmental or inter-institutional collaboration and available clinical, laboratory, data-management, equipment, and infrastructure support.

15. Budget

Provide a detailed and appropriate budget, including justification for staff, their roles and responsibilities, and each proposed budget component.

7. Declaration form

I certify that the project entitled:

“____________________________________________”

has been submitted to the following funding agency or institution other than the Karnataka Rheumatology Association (KRA):

1.

2.

3.

I certify to update KRA if any other funding received at a later date before completion of project not already disclosed above.

The authors are encouraged to consider submitting the resulting work to the Indian Journal of Rheumatology for consideration of publication.

Signature of Principal Investigator/Guide/Mentor: __________________

Date: __________________



How to apply?

Attach the completed research proposal and declaration forms in PDF format and submit the following form. 






    Upload your completed research proposal. PDF only, maximum 5 MB.



    Upload your completed declaration. PDF only, maximum 5 MB.